Literature DB >> 8837026

Natural catalytic antibodies.

S Paul1.   

Abstract

Catalytic activity can arise by natural means in antibodies. Several naturally-occurring peptides and synthetic protease substrates are known to be cleaved by antibodies. There is an increased production of antigen-specific catalytic antibodies in autoimmune disease. Antibody light chains isolated from multiple myeloma patients frequently express proteolytic activity. Immunization protocols using as antigens the ground state of a naturally-occurring polypeptide, transition state analogs or anti-enzyme antibodies are known to provoke catalytic antibody synthesis. Active site residues in the light chain subunit serve as the catalytic residues in an antibody with peptide bond cleaving activity. Mutagenesis in the active site can potentially generate improved catalysts. The possible mechanisms underlying proteolysis by natural antibodies and evolution of the catalytic activity are reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837026     DOI: 10.1007/bf02900358

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  43 in total

1.  Solution structure of an analogue of vasoactive intestinal peptide as determined by two-dimensional NMR and circular dichroism spectroscopies and constrained molecular dynamics.

Authors:  D C Fry; V S Madison; D R Bolin; D N Greeley; V Toome; B B Wegrzynski
Journal:  Biochemistry       Date:  1989-03-21       Impact factor: 3.162

2.  Selection of human immunoglobulin light chains from a phage-display library.

Authors:  S Tyutyulkova; Q S Gao; S Paul
Journal:  Methods Mol Biol       Date:  1995

3.  Molecular cloning of antiground-state proteolytic antibody fragments.

Authors:  Q S Gao; S Paul
Journal:  Methods Mol Biol       Date:  1995

4.  Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten: an esterase-like activity of the antibody-containing site?

Authors:  F Kohen; J B Kim; H R Lindner; Z Eshhar; B Green
Journal:  FEBS Lett       Date:  1980-03-10       Impact factor: 4.124

5.  Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (c-ANCA) by dysregulation of the enzyme.

Authors:  K M Dolman; B A van de Wiel; C M Kam; J E Kerrigan; C E Hack; A E von dem Borne; J C Powers; R Goldschmeding
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

6.  Site-directed mutagenesis of proteolytic antibody light chain.

Authors:  Q S Gao; M Sun; A R Rees; S Paul
Journal:  J Mol Biol       Date:  1995-11-10       Impact factor: 5.469

7.  Antigen recognition by an antibody light chain.

Authors:  M Sun; L Li; Q S Gao; S Paul
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

8.  Making antibody fragments using phage display libraries.

Authors:  T Clackson; H R Hoogenboom; A D Griffiths; G Winter
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

9.  Electrostatic complementarity within the substrate-binding pocket of trypsin.

Authors:  L Gráf; A Jancsó; L Szilágyi; G Hegyi; K Pintér; G Náray-Szabó; J Hepp; K Medzihradszky; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment.

Authors:  S Paul; L Li; R Kalaga; P Wilkins-Stevens; F J Stevens; A Solomon
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

View more
  9 in total

1.  Some Bence-Jones proteins enter cultured renal tubular cells, reach nuclei and induce cell death.

Authors:  K Matsuura; S Ikoma; M Watanabe; A Togawa; H Sinohara
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 2.  Antibodies as defensive enzymes.

Authors:  Sudhir Paul; Yasuhiro Nishiyama; Stephanie Planque; Sangeeta Karle; Hiroaki Taguchi; Carl Hanson; Marc E Weksler
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

3.  Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12.

Authors:  V P Van Keulen; B Ciric; S Radhakrishnan; K L Heckman; Y Mitsunaga; K Iijima; H Kita; M Rodriguez; L R Pease
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Authors:  Gopal Sapparapu; Stephanie A Planque; Yasuhiro Nishiyama; Steven K Foung; Sudhir Paul
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

5.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

6.  Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Authors:  Yukie Mitsuda; Stephanie Planque; Mariko Hara; Robert Kyle; Hiroaki Taguchi; Yasuhiro Nishiyama; Sudhir Paul
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

7.  Amidolytic and peptidolytic activities of immunoglobulin G present in sera from patients with rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus.

Authors:  K Matsuura; S Ikoma; M Sugiyama; M Funauchi; H Sinohara
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

8.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections.

Authors:  Taisiya A Parkhomenko; Elena S Odintsova; Valentina N Buneva; Elena V Kunder; Ivan V Zhyltsov; Sergey A Senkovich; Igor I Generalov; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2008-07-29       Impact factor: 5.310

9.  Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24.

Authors:  Sarah M Gunter; Kathryn M Jones; Bin Zhan; Heather T Essigmann; Kristy O Murray; Melissa N Garcia; Rodion Gorchakov; Maria Elena Bottazzi; Peter J Hotez; Eric L Brown
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.